Biogen Idec Stock Rating Reaffirmed by Piper Jaffray (BIIB) Zolmax ... in particular unpublished estimates) now fully reflect Tecfidera's strong launch, in our view, and upside in BIIB shares will likely require pipeline success, which is not expected until 2014 data readouts from anti-LINGO Phase II (optic neuritis ... |
